Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN102249976B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102249976B discloses a scalable route to (-)-clausenamide using fructose-derived catalysts, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.